🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Henan Provincial People's Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Henan Provincial People's Hospital as lead sponsor. Synced 27 Sep 2026
15Current trials
7Recruiting now
3Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Henan Provincial People's Hospital is the lead sponsor of 15 current clinical trials in our China register. 7 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Bevacizumab, Tislelizumab and Nicotine. The most-studied condition is Glioblastoma.

ClinicalTrials.gov trials by status

  • Recruiting747%
  • Not yet open640%
  • By invitation213%

Trials by phase

  • Observational640%
  • Not applicable533%
  • Phase 2427%
01

Clinical trials sponsored by Henan Provincial People's Hospital

15 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes
NCT07674004 · ClinicalTrials.gov ↗ · Intracranial Aneurysms, Flow Diverter
Not applicable Recruiting 2026-05 China
Application of HFNC for the Prevention of Hypoxemia During Perioperative Anesthetic-induced Intubation in Children: A Randomized Controlled Clinical Trial
NCT06425406 · ClinicalTrials.gov ↗ · High-flow Nasal Cannula, Children, Pre-oxygenation
Not applicable Recruiting 2024-06 China
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma
NCT05512351 · ClinicalTrials.gov ↗ · Oligodendroglioma
Phase 2 Recruiting 2022-12 China
Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
NCT07614594 · ClinicalTrials.gov ↗ · Urothelial Carcinoma (UC), Upper Tract Urothelial Carcinoma, UTUC
Observational Recruiting 2019-10 China
NOACs Use in AF or VTE (SUNSHINE Registry)
NCT05378308 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Venous Thromboembolism, Oral Anticoagulant
Observational Recruiting 2022-06 China
Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation
NCT06145906 · ClinicalTrials.gov ↗ · Atrial Fibrillation
Observational Recruiting 2023-12 China
Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Undergoing Thoracic Surgery: A Randomized Controlled Pilot Study
NCT07250230 · ClinicalTrials.gov ↗ · Nicotine Dependence, Thoracic Diseases, Analgesia
Drug: Nicotine
Not applicable Recruiting 2025-11 China
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
NCT05502991 · ClinicalTrials.gov ↗ · Glioblastoma
Phase 2 Not yet open 2022-12 China
Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
NCT05541042 · ClinicalTrials.gov ↗ · Glioblastoma
Observational Not yet open 2022-12 China
Tislelizumab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for Bevacizumab Refractory Recurrent Glioblastoma
NCT05540275 · ClinicalTrials.gov ↗ · Recurrent Glioblastoma
Phase 2 Not yet open 2023-10 China
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma
NCT05518994 · ClinicalTrials.gov ↗ · Astrocytoma of Brain
Phase 2 Not yet open 2022-12 China
Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma
NCT05532969 · ClinicalTrials.gov ↗ · Astrocytoma
Observational Not yet open 2022-12 China
Study on Gene Evolution in Glioma Under Stress Therapy
NCT05512325 · ClinicalTrials.gov ↗ · Genetic Change
Observational Not yet open 2022-12 China
Dynamic Effects of Different Anesthetic Agents on the Immune Function of Healthy Volunteers
NCT07268872 · ClinicalTrials.gov ↗ · Immune System
Not applicable By invitation 2025-11 China
Efficacy of Three Gingival Displacement Methods
NCT07282977 · ClinicalTrials.gov ↗ · Tooth Defect, Teeth Restoration
Not applicable By invitation 2025-12 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Henan Provincial People's Hospital trials

3 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Henan Provincial People's Hospital trials

24 conditions
Glioblastoma2Atrial Fibrillation2Intracranial Aneurysms1Flow Diverter1High-flow Nasal Cannula1Children1Pre-oxygenation1Immune System1Oligodendroglioma1Urothelial Carcinoma (UC)1Upper Tract Urothelial Carcinoma1UTUC1Bladder Cancer (BC)1Recurrent Glioblastoma1Venous Thromboembolism1Oral Anticoagulant1Astrocytoma of Brain1Astrocytoma1Tooth Defect1Teeth Restoration1Genetic Change1Nicotine Dependence1Thoracic Diseases1Analgesia1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China157

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Glioblastoma

SponsorTrials
Erasmus Medical Center6
Jasper Gerritsen5
University of Zurich3
Peter Siesjö3
NovoCure2
Telix Pharmaceuticals (Innovations) Pty2
Philogen2
GT Medical Technologies2
Centre Paul Strauss2
Nerviano Medical Sciences1

Sponsors with the most current trials registered for this condition.

06

Questions about Henan Provincial People's Hospital trials

How many clinical trials does Henan Provincial People's Hospital sponsor?

Henan Provincial People's Hospital is the lead sponsor of 15 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Henan Provincial People's Hospital trials recruiting?

Yes. 7 of its 15 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Henan Provincial People's Hospital testing?

Its current trials name 3 drugs and biologicals as interventions. The most frequent are Bevacizumab (4), Tislelizumab (4) and Nicotine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.